Insulin Pumps Edge Injections for T1D Glycemic Control
Health Canada Clears MiniMed 770G Automated Insulin Delivery System
EU Approves Novo Nordisk's Pre-filled Insulin Cartridge for the New Accu-Chek Insight Insulin Pump
Treating Type 2 Diabetes | Medtronic
FDA Approves Fiasp® For Use In Insulin Pumps for Adults with T1 and T2 Diabetes | dLife
Researchers test an artificial pancreas in outpatients with type 2 diabetes
Abbott's diabetes deals • Sinai to close subacute unit • Medicare open enrollment | Crain's Chicago Business
The Latest and Greatest in Insulin Pumps and Sensor Technology - Taking Control Of Your Diabetes®
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial - The Lancet Digital Health
Insulin pump therapy can be initiated in primary care
Global Insulin Pump Market Outlook and Forecast to 2028: Featuring Insulet, Medtronic, Tandem Diabetes Care, CeQur Simplicity and EOFLOW Among Others
Novo Nordisk introduces NovoRapid PumpCart insulin pump
New Delivery Devices Make Taking Insulin Easier
Diabetes Management Technologies 2022-2032: Markets, Players, and Forecasts: IDTechEx
Novo Nordisk Insulin Pen Certification | novoMEDLINK™
The Pros and Cons of Insulin Pump Therapy | Insulin Nation
Endocrinology Group Calls for Better Insulin-Pump Training
Omnipod + Fiasp is cleared in Europe — JUICEBOX PODCAST
Nonprofit drugmaker will soon sell insulin for $30 a vial, regardless of insurance | WPMI
A Technology Laggard's Foray into Insulin Pumps and Continuous Sensors
Novo Nordisk and Roche' insulin pump system gets EU thumbs up
With new Medtronic pact, Novo Nordisk's smart insulin pen to link with all major CGMs | Fierce Biotech
Bionic pancreas improves type 1 diabetes management compared to standard insulin delivery methods | National Institutes of Health (NIH)
Treating Type 2 Diabetes | Medtronic
Treating Type 2 Diabetes | Medtronic
